Sanofi Consumer Healthcare India’s Q3 revenue rises 12% to Rs 263 Cr

Domestic sales grew 15% during the nine-month period

Zeus Hygia targets next wave of sports nutrition with CreaStab & CXR Energy

CPHI India & PMEC India 2026 to bring 50,000+ pharma professionals together

Dual events to spotlight India’s manufacturing aspirations

Strides Pharma’s ex-US business surges 31%, overtakes US for first time

Pharma major crosses Rs 14,000 million quarterly revenue milestone

Sanofi India’s Q3 profit before tax jumps 22% as diabetes portfolio grows 9%

The growth was driven by a resilient diabetes portfolio, robust export performance and tighter cost management

Laurus Labs Q2 profit surges 126% to Rs 441 crore; revenue jumps 33% to Rs 2,206 crore

The strong quarterly performance was backed by improved gross margins, which increased to 63% from 59.9% in the year-ago quarte

Merck opens €300 million bioprocessing centre in South Korea

Hikal bags Swissmedic GMP approval for Bengaluru API facility

The certification elevates the site’s global regulatory status, opening doors to European and other highly regulated markets

Alivus Life Sciences Q2 profit jumps 51.3%; EBITDA margin hits record 41.8%

Senores Pharmaceuticals posts record Q2 revenue & EBITDA

Company reports 25% revenue growth in Q2, 30% in H1; PAT rises 22% and 31%, respectively

Mankind Pharma’s Q2 profit jumps 38% as revenue rises 17% to Rs 4,338 Cr

Domestic business grows 15.9%; EBITDA climbs 27% as margins expand 210 basis points

Astec LifeSciences’ Q2 loss widens to Rs 37.4 crore as EBITDA deteriorates

Astec’s performance remained under pressure during the first half of FY27

Sudeep Pharma gets FDA nod for new Gujarat facility

Approval clears the way for manufacturing at Nandesari plant, with commercial supplies expected to begin in H2 FY27

Novartis raises 2026 profit outlook as Q3 sales rise 4%

Priority medicines drive growth and margins expand, but a $1.9 billion impairment sends operating income tumbling 59%

Roche wins CE Mark for compact immunoanalyser targeting diagnostic delays in smaller labs

The standalone system occupies less than one square metre and has a planned menu of more than 100 high-medical-value assays

Morepen Laboratories posts record Rs 755-cr Q2 revenue; EBITDA soars 273% to Rs 132 cr

Bayer bags China nod for world’s first Factor XIa inhibitor for stroke prevention

The approval makes Sunharbo the first Factor XIa inhibitor approved worldwide

AIG Hospitals & Boston Scientific partner to train doctors in advanced GI care

The training will extend beyond doctors to include endoscopy technicians and nursing professionals, recognising the importance of coordinated

AstraZeneca lung cancer drug combination cuts risk of death by 32%

The progression-free survival benefit was consistent across all prespecified subgroups

Orchid Pharma inks $80-million Latin America deal to expand antibiotic Exblifep across nine markets

Commercialisation in each market will be subject to approval by the respective national regulatory authority